{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T21:39:10Z","timestamp":1782682750464,"version":"3.54.5"},"reference-count":48,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0138","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T22:07:31Z","timestamp":1603145251000},"page":"281-289","source":"Crossref","is-referenced-by-count":17,"title":["The association between type 1 and 2 diabetes mellitus and the risk of leukemia: a systematic review and meta-analysis of 18 cohort studies"],"prefix":"10.1507","volume":"68","author":[{"given":"Pengfei","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery II, Renmin Hospital, Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Statistics and Management, School of Management, Wuhan Institute of Technology, Wuhan 430205, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Juliusson G, Hough R (2016) Leukemia. Prog Tumor Res 43: 87\u2013100.","DOI":"10.1159\/000447076"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Kampen KR (2012) The discovery and early understanding of leukemia. Leuk Res 36: 6\u201313.","DOI":"10.1016\/j.leukres.2011.09.028"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68: 394\u2013424.","DOI":"10.3322\/caac.21492"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Zimmet P, Alberti KG, Magliano DJ, Bennett PH (2016) Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol 12: 616\u2013622.","DOI":"10.1038\/nrendo.2016.105"},{"key":"5","unstructured":"5 International Diabetes Federation (IDF) (2017) IDF Diabetes Atlas Eighth 12 Edition, https:\/\/diabetesatlas.org\/resources\/2017-atlas.html [Accessed 2020.09.02]"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Wang Y, Liu X, Yan P, Bi Y, Liu Y, et al. (2020) Association between type 1 and type 2 diabetes and risk of non-Hodgkin\u2019s lymphoma: a meta-analysis of cohort studies. Diabetes Metab 46: 8\u201319.","DOI":"10.1016\/j.diabet.2019.04.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Zhang ZJ (2014) Re: \u201cType 2 diabetes and the risk of colorectal adenomas: Black Women\u2019s Health Study\u201d. Am J Epidemiol 179: 1276\u20131277.","DOI":"10.1093\/aje\/kwu088"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350: g7607.","DOI":"10.1136\/bmj.g7607"},{"key":"9","unstructured":"9 Xu Y, Huo R, Chen X, Yu X (2017) Diabetes mellitus and the risk of bladder cancer: a PRISMA-compliant meta-analysis of cohort studies. Medicine (Baltimore) 96: e8588."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J (2012) Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood 119: 4845\u20134850.","DOI":"10.1182\/blood-2011-06-362830"},{"key":"11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/1471-2458-12-567","volume":"12","author":"PH Zhang","year":"2012","unstructured":"11 Zhang PH, Chen ZW, Lv D, Xu YY, Gu WL, et al. (2012) Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China. BMC Public Health 12: 567.","journal-title":"BMC Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2458","issn-type":"print"},{"key":"12","unstructured":"12 Lai GY, Park Y, Hartge P, Hollenbeck AR, Freedman ND (2013) The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study. J Clin Endocrinol Metab 98: E497\u2013E502."},{"key":"13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2407-14-381","volume":"14","author":"CC Lin","year":"2014","unstructured":"13 Lin CC, Chiang JH, Li CI, Liu CS, Lin WY, et al. (2014) Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan. BMC Cancer 14: 381.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ (2015) Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 38: 264\u2013270.","DOI":"10.2337\/dc14-1996"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Liu X, Hemminki K, Forsti A, Sundquist K, Sundquist J, et al. (2015) Cancer risk in patients with type 2 diabetes mellitus and their relatives. Int J Cancer 137: 903\u2013910.","DOI":"10.1002\/ijc.29440"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Carstensen B, Read SH, Friis S, Sund R, Keskimaki I, et al. (2016) Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals. Diabetologia 59: 980\u2013988.","DOI":"10.1007\/s00125-016-3884-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Dankner R, Boffetta P, Balicer RD, Boker LK, Sadeh M, et al. (2016) Time-dependent risk of cancer after a diabetes diagnosis in a cohort of 2.3 million adults. Am J Epidemiol 183: 1098\u20131106.","DOI":"10.1093\/aje\/kwv290"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Gini A, Bidoli E, Zanier L, Clagnan E, Zanette G, et al. (2016) Cancer among patients with type 2 diabetes mellitus: a population-based cohort study in northeastern Italy. Cancer Epidemiol 41: 80\u201387.","DOI":"10.1016\/j.canep.2016.01.011"},{"key":"19","doi-asserted-by":"crossref","first-page":"e020827","DOI":"10.1136\/bmjopen-2017-020827","volume":"8","author":"R Williams","year":"2018","unstructured":"19 Williams R, van Staa TP, Gallagher AM, Hammad T, Leufkens HGM, et al. (2018) Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort study. BMJ Open 8: e020827.","journal-title":"BMJ Open","ISSN":"https:\/\/id.crossref.org\/issn\/2044-6055","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Qi J, He P, Yao H, Song R, Ma C, et al. (2019) Cancer risk among patients with type 2 diabetes: a real-world study in Shanghai, China. J Diabetes 11: 878\u2013883.","DOI":"10.1111\/1753-0407.12926"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Saarela K, Tuomilehto J, Sund R, Keskimaki I, Hartikainen S, et al. (2019) Cancer incidence among Finnish people with type 2 diabetes during 1989\u20132014. Eur J Epidemiol 34: 259\u2013265.","DOI":"10.1007\/s10654-018-0438-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25: 603\u2013605.","DOI":"10.1007\/s10654-010-9491-z"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177\u2013188.","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Ragozzino M, Melton LJ 3rd, Chu CP, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35: 13\u201319.","DOI":"10.1016\/0021-9681(82)90025-X"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, et al. (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89: 1360\u20131365.","DOI":"10.1093\/jnci\/89.18.1360"},{"key":"26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","volume":"293","author":"SH Jee","year":"2005","unstructured":"26 Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, et al. (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194\u2013202.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, et al. (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92: 2070\u20132075.","DOI":"10.1038\/sj.bjc.6602611"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Shu X, Ji J, Li X, Sundquist J, Sundquist K, et al. (2010) Cancer risk among patients hospitalized for type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med 27: 791\u2013797.","DOI":"10.1111\/j.1464-5491.2010.03011.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2011) Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 128: 635\u2013643.","DOI":"10.1002\/ijc.25362"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Wotton CJ, Yeates DG, Goldacre MJ (2011) Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies. Diabetologia 54: 527\u2013534.","DOI":"10.1007\/s00125-010-1987-2"},{"key":"31","unstructured":"32 Duan W, Shen X, Lei J, Xu Q, Yu Y, et al. (2014) Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int 2014: 461917."},{"key":"32","doi-asserted-by":"publisher","unstructured":"33 Fabiani R, Minelli L, Bertarelli G, Bacci S (2016) A western dietary pattern increases prostate cancer risk: a systematic review and meta-analysis. Nutrients 8: 626.","DOI":"10.3390\/nu8100626"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34 Liu P, Holman CD, Jin J, Zhang M (2015) Diet and risk of adult leukemia: a multicenter case-control study in China. Cancer Causes Control 26: 1141\u20131151.","DOI":"10.1007\/s10552-015-0608-2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35 Solans M, Castell\u00f3 A, Benavente Y, Marcos-Gragera R, Amiano P, et al. (2018) Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study. Haematologica 103: 1881\u20131888.","DOI":"10.3324\/haematol.2018.192526"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36 Abar L, Sobiecki JG, Cariolou M, Nanu N, Vieira AR, et al. (2019) Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies. Ann Oncol 30: 528\u2013541.","DOI":"10.1093\/annonc\/mdz045"},{"key":"36","doi-asserted-by":"publisher","unstructured":"37 Ye H, Adane B, Khan N, Alexeev E, Nusbacher N, et al. (2018) Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells. Cancer Cell 34: 659\u2013673.e6.","DOI":"10.1016\/j.ccell.2018.08.016"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38 Zhang JJ, Jia JP, Shao Q, Wang YK (2019) Diabetes mellitus and risk of pancreatic cancer in China: a meta-analysis based on 26 case-control studies. Prim Care Diabetes 13: 276\u2013282.","DOI":"10.1016\/j.pcd.2018.11.015"},{"key":"38","unstructured":"39 Feltbower RG, McKinney PA, Greaves MF, Parslow RC, Bodansky HJ (2004) International parallels in leukaemia and diabetes epidemiology. Arch Dis Child 89: 54\u201356."},{"key":"39","doi-asserted-by":"crossref","unstructured":"40 Feltbower RG, Manda SO, Gilthorpe MS, Greaves MF, Parslow RC, et al. (2005) Detecting small-area similarities in the epidemiology of childhood acute lymphoblastic leukemia and diabetes mellitus, type 1: a Bayesian approach. Am J Epidemiol 161: 1168\u20131180.","DOI":"10.1093\/aje\/kwi146"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41 Richiardi L, Magnani C, Bruno G, Maule MM, Merletti F, et al. (2005) Re: \u201cDetecting small-area similarities in the epidemiology of childhood acute lymphoblastic leukemia and diabetes mellitus, type 1: a Bayesian approach\u201d. Am J Epidemiol 162: 1132\u20131133.","DOI":"10.1093\/aje\/kwi333"},{"key":"41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1186\/1471-2407-14-985","volume":"14","author":"DJ Crawley","year":"2014","unstructured":"42 Crawley DJ, Holmberg L, Melvin JC, Loda M, Chowdhury S, et al. (2014) Serum glucose and risk of cancer: a meta-analysis. BMC Cancer 14: 985.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43 Lee SC, Chan JC (2015) Evidence for DNA damage as a biological link between diabetes and cancer. Chin Med J (Engl) 128: 1543\u20131548.","DOI":"10.4103\/0366-6999.157693"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44 Fitter S, Vandyke K, Schultz CG, White D, Hughes TP, et al. (2010) Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: a mechanism for improved insulin sensitivity in type 2 diabetic CML patients? J Clin Endocrinol Metab 95: 3763\u20133767.","DOI":"10.1210\/jc.2010-0086"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45 Agostino NM, Chinchilli VM, Lynch CJ, Koszyk-Szewczyk A, Gingrich R, et al. (2011) Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. J Oncol Pharm Pract 17: 197\u2013202.","DOI":"10.1177\/1078155210378913"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46 Heckman-Stoddard BM, DeCensi A, Sahasrabuddhe VV, Ford LG (2017) Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia 60: 1639\u20131647.","DOI":"10.1007\/s00125-017-4372-6"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47 Cunha Junior AD, Pericole FV, Carvalheira JBC (2018) Metformin and blood cancers. Clinics (Sao Paulo) 73: e412s.","DOI":"10.6061\/clinics\/2018\/e412s"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48 Wang Y, Fu T, Liu Y, Yang G, Yu C, et al. (2020) The association between metformin and head and neck cancer survival: a systematic review and meta-analysis of cohort studies. Curr Pharm Des 26: 3161\u20133170.","DOI":"10.2174\/1381612826666200218095310"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49 Wang Y, Liu X, Yan P, Tang J, Chen T, et al. (2020) Effect of metformin on the risk of prostate cancer in patients with type 2 diabetes by considering different confounding factors: a meta-analysis of observational studies. Eur J Cancer Prev 29: 42\u201352.","DOI":"10.1097\/CEJ.0000000000000514"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/3\/68_EJ20-0138\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T03:26:31Z","timestamp":1617420391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/3\/68_EJ20-0138\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0138","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}